| 1. |
|
|
| 2. |
|
|
| 3. |
- Kotova, Olga
(author)
-
Signaling to and from the sodium pump : effects of insulin and cardiotonic steroids
- 2006
-
Doctoral thesis (other academic/artistic)abstract
- Insulin and proinsulin-connecting peptide (C-peptide) stimulate Na+,K+-ATPase activity. The molecular mechanism by which insulin and C-peptide regulate the Na-pump in differentiated primary human skeletal muscle cells (HSMCs) and primary human renal tubular cells (HRTCs) was determined. Insulin- and C-peptide stimulated Na+,K+-ATPase activation, as assessed by ouabain-sensitive 86Rb+ uptake and 3H-ouabain binding, phosphorylation of α- and translocation of α- and β-subunits to plasma membrane from intracellular stores. These effects were abolished by the MEK1/2 inhibitor (PD98059). Furthermore, inhibitors of PI3 kinase (wortmannin) and PKC (GF109203X) had similar effects. Notably, insulin-stimulated ERK1/2 phosphorylation was abolished by wortmannin and GF109203X. Insulin led to an increase in phosphorylation of the α1- and α2-subunits. C-peptide caused phosphorylation of the human α1-subunit on a Thr-Pro amino acid motif that confers a specific ERK phosphorylation site. ERK1 and 2 kinases were able to phosphorylate the α-subunit of purified human Na-pump in vitro. Thus, insulin and C-peptide activate Na+,K+-ATPase via a MAP kinase signaling pathway. Exercise and in vitro skeletal muscle contraction leads to a significant increase in the plasma membrane abundance of the Na-pump α1- and α2-subunits via an ERK1/2 MAPK-dependent mechanism. Cardiotonic steroids (CTS) initiate signaling cascade through the Na+,K+-ATPase, and increase growth and proliferation of different cell types. The effects of cardiotonic steroids, ouabain and marinobufagenin, on glucose metabolism in HSMC and rat skeletal muscle were explored in an effort to clarify the mechanisms of CTS signal transduction. Ouabain at a low dose increased glycogen synthesis additively to the effect of insulin. This effect was independent of PI3-kinase inhibitor LY294002, and abolished in the presence of either the MEK1/2 inhibitor PD98059 or the Src inhibitor PP2. Insulin-stimulated Akt phosphorylation was unaffected by ouabain. Ouabain increased Src-dependent tyrosine phosphorylation of the α1- and α2-subunits and promoted a direct interaction of α-subunits with Src and formation of signaling complex. Phosphorylation of ERK1/2, GSK3α/β and p90rsk activity, were increased in response to ouabain independently of insulin action. These effects were prevented in the presence of PD98059 and PP2. Incubation of cells with ouabain increased phosphorylation of the α-subunits at a Thr-Pro motif. Ouabain treatment decreased cell surface abundance of the α2-subunit, whereas the abundance of the α1-subunit was unchanged. Marinobufagenin (10 nM), an endogenous vertebrate bufadienolide cardiotonic steroid, increased glycogen synthesis in HSMC and this effect was similar to that observed in cells exposed to 100 nM ouabain. Incubation of skeletal muscle with ouabain did not induce metabolic stress. In conclusion, activation of a MAPK signaling cascade stimulates Na+,K+-ATPase activity via phosphorylation of the α-subunits and translocation to plasma membrane. Cardiotonic steroids ouabain and marinobufagenin stimulate glycogen synthesis additively to insulin in skeletal muscle. The effect of cardiotonic steroids is mediated by activation of Src-, ERK1/2-, p90rsk-, and GSK3-dependent signaling pathway.
|
|
| 4. |
|
|
| 5. |
- Prokunina-Olsson, Ludmila, et al.
(author)
-
Tissue-specific alternative splicing of TCF7L2
- 2009
-
In: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 18:20, s. 3795-3804
-
Journal article (peer-reviewed)abstract
- Common variants in the transcription factor 7-like 2 (TCF7L2) gene have been identified as the strongest genetic risk factors for type 2 diabetes (T2D). However, the mechanisms by which these non-coding variants increase risk for T2D are not well-established. We used 13 expression assays to survey mRNA expression of multiple TCF7L2 splicing forms in up to 380 samples from eight types of human tissue (pancreas, pancreatic islets, colon, liver, monocytes, skeletal muscle, subcutaneous adipose tissue and lymphoblastoid cell lines) and observed a tissue-specific pattern of alternative splicing. We tested whether the expression of TCF7L2 splicing forms was associated with single nucleotide polymorphisms (SNPs), rs7903146 and rs12255372, located within introns 3 and 4 of the gene and most strongly associated with T2D. Expression of two splicing forms was lower in pancreatic islets with increasing counts of T2D-associated alleles of the SNPs: a ubiquitous splicing form (P = 0.018 for rs7903146 and P = 0.020 for rs12255372) and a splicing form found in pancreatic islets, pancreas and colon but not in other tissues tested here (P = 0.009 for rs12255372 and P = 0.053 for rs7903146). Expression of this form in glucose-stimulated pancreatic islets correlated with expression of proinsulin (r(2) = 0.84-0.90, P < 0.00063). In summary, we identified a tissue-specific pattern of alternative splicing of TCF7L2. After adjustment for multiple tests, no association between expression of TCF7L2 in eight types of human tissue samples and T2D-associated genetic variants remained significant. Alternative splicing of TCF7L2 in pancreatic islets warrants future studies. GenBank Accession Numbers: FJ010164-FJ010174.
|
|
